S

00719

Shandong Xinhua Pharmaceutical

6.71

-0.12-1.76%
Opening13:53 12/16 HKT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE6.800/6.830
TODAY RANGE6.700-6.810
VOL1.24M
MARKET CAP4.63B
52 WEEK RANGE5.110-9.460
AVG VOL (3M)2.20M
% TURNOVER0.18%
TURNOVER8.37M
P/E (TTM)11.058
% RANGE1.61%
EPS(TTM)0.607
P/E(FORWARD)8.766
P/B0.821
BVPS8.176
DIVIDEND0.273
P/S0.497
BETA--
DIV YIELD4.07%
FREE FLOAT MKT CAP1.31B
SHARES OUTSTANDING689.78M
NEXT EARNINGS03/30-04/03
FREE FLOAT195.00M
LOT SIZE2000
EX-DATE06/27/2025
Feeds
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

S

Shandong Xinhua Pharmaceutical

00719

-1.76%
6.710

A

Amgen

04332

--

C

China Conch Venture Holdings

00586

-2.10%
9.780

W

Wuxi Apptec

02359

-1.46%
101.000

A

Asymchem Laboratories (Tianjin)

06821

-1.47%
73.550

S

Sinopharm Group

01099

-2.00%
19.560

G

Guangzhou Baiyunshan Pharmaceutical Holdings

00874

-1.34%
18.400

L

Livzon Pharmaceutical Group

01513

-2.68%
29.100

S

Shanghai Pharmaceuticals Holding

02607

-1.52%
11.670

S

Shanghai Fosun Pharmaceutical (Group)

02196

-6.62%
20.880

C

China Medical System Holdings

00867

-0.23%
13.230

S

SciClone Pharmaceuticals (Holdings)

06600

0.00%
18.720

C

China Isotope & Radiation

01763

-0.88%
20.360

W

Wuxi Biologics (Cayman)

02269

-1.79%
31.860

C

China Shineway Pharmaceutical Group

02877

-1.44%
8.210

T

The United Laboratories International Holdings

03933

-1.80%
12.020

C

Consun Pharmaceutical Group

01681

-1.34%
14.700

3

3SBio

01530

-3.20%
25.400

B

Beijing Tong Ren Tang Chinese Medicine

03613

-1.39%
8.510

C

China Resources Pharmaceutical Group

03320

-1.75%
4.500

C

CSPC Pharmaceutical Group

01093

-3.06%
7.280
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.